CT Cardiomegaly vs PMcardio

PMcardio offers a user-friendly mobile app (iOS and Android) and web platform, allowing for instant ECG analysis by simply taking a photo of a 12-lead ECG. This broad accessibility and intuitive interface contrast with CT Cardiomegaly's command-line software deployment, which typically requires more technical expertise and integration into existing systems. While CT Cardiomegaly outputs PDF and JSON reports, PMcardio's mobile and web access, along with its visual AI explainability with heatmaps, likely provides a more direct and immediate user experience for clinicians at the point of care.

PMcardio demonstrates broader clinical value by interpreting ECGs for over 50 cardiac conditions, including critical detections like STEMI/OMI and reduced LVEF, and has been clinically validated in more than 25 studies. CT Cardiomegaly focuses on a single measurementu2014cardiothoracic ratio from CT imagesu2014to assist in cardiomegaly detection. While both are FDA/CE cleared, PMcardio's wider diagnostic scope and extensive validation suggest a more comprehensive impact on clinical decision-making.

PMcardio offers a freemium model with 5 free ECG analyses per month, making it accessible for individual clinicians to try before committing to a paid plan. Its transparent pricing for individuals and teams, along with enterprise options, provides clear value propositions. CT Cardiomegaly requires contacting the vendor for pricing, which offers less transparency upfront. PMcardio's ability to detect over 50 cardiac conditions also suggests a higher value for its cost compared to CT Cardiomegaly's single-purpose measurement.

PMcardio is designed for enterprise deployment with integrations into EHR/CVIS and EMS systems, offering a unified cardiac AI platform for various care settings. It provides enterprise-grade security (GDPR, HIPAA, ISO 27001, SOC 2 compliant) and features like central report management and role-based access control. CT Cardiomegaly, while deployable as a Docker container and HIPAA compliant, is a command-line tool, which may require more bespoke integration efforts and lacks the explicit enterprise-level features and certifications highlighted by PMcardio.

PMcardio showcases greater innovation with its AI explainability feature (ECGxplainu2122) using heatmaps to visualize the AI's decision-making, fostering trust and understanding. It also offers detection of 50+ cardiac conditions, including advanced features like Queen of Heartsu2122 for STEMI/OMI detection and LVsenseu2122 for reduced LVEF. CT Cardiomegaly, while utilizing machine learning for segmentation, focuses on a more established measurement (cardiothoracic ratio) without explicitly detailing comparable innovative features beyond automated measurement.

PMcardio provides a Help Center with instructions for use for individuals, covering various AI ECG models and available in multiple languages. They also offer email support and dedicated onboarding sessions for teams and organizations. While Innolitics (the company behind CT Cardiomegaly) offers regulatory strategy and development services, specific details on ongoing product support and documentation for CT Cardiomegaly itself are less prominent than PMcardio's readily available resources.